Why Sagility Is Gaining Attention Amid Rising US Healthcare Outsourcing Demand?

Synopsis: Sagility remains in focus as rising cost pressures and regulatory complexity in the US healthcare sector continue to drive outsourcing demand. Strong domain expertise, AI-led efficiency solutions, and deeper client expansion support its long-term growth visibility. 

The shares of this IT company majorly engaged in providing healthcare-focused technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments, were in focus after the brokerage firm saw around 45 percent upside potential based on the strong earning visibility. 

With the market capitalization of Rs. 19,530 Crores, the shares of Sagility Ltd were trading at around 41.7 per share, which is 27 percent discount from its 52-week high of Rs. 57.9 per share and is trading at a P/E of 22.4 whereas industry P/E stands at 22.5

Long-term demand tailwinds from the US healthcare ecosystem

The investor day held by Sagility emphasized the point that the US healthcare ecosystem is plagued by structural inefficiencies. This is one area that provides long-term growth opportunities for the company. The discussion held during the investor presentation focused on the company’s offerings in the payer and provider segment, disruptions in the US healthcare system, profitability pressure on clients, changing customer needs, and the impact of AI in improving services. 

The growth drivers for the company are based on four major pillars: cost transformation driven by the demand in the US payer segment, capability-based differentiation including AI, in-depth penetration of existing clients with new statements of work, and compliance-based initiatives.

The company is expected to witness low to mid-teens revenue growth with increasing volumes in the top clients, new clients added to the portfolio, cross-selling opportunities, and synergies arising out of the Broadpath acquisition. Accordingly, the revenue/EBIT/PAT growth at a compound annual growth rate of 20 percent /28 percent /23 percent  over FY25 to FY28 provides long-term growth prospects.

Rising cost pressure on US payers supports outsourcing demand

One of the key reasons for the growth of Sagility is the pressure that the US healthcare payer system is currently going through. The system is currently going through a number of disruptions, including CMS rate revisions, ACA subsidy-related changes, tariff-related changes, H1-B visa-related changes, and the “One Big Beautiful Bill Act” (OBBBA), all of which are putting pressure on the medical costs of insurance payers.

This, in turn, is leading to a more efficient management of profitability, compliance, growth, and utilization management for payer organizations, leading to a greater need for outsourcing and technology-based operating models, which in turn is leading to a greater volume of work for players like Sagility.

Healthcare-specific capabilities create a strong competitive edge

The emphasis in the report on Sagility’s domain expertise is quite strong. For instance, the company has developed predictive models, business intelligence systems, bots for automation, agents with Gen AI leadership, and interoperability solutions that are all tailored for the healthcare domain.

The solutions are developed under SOC 2 and HITRUST-compliant controls. This is important in the healthcare industry because of the privacy and security concerns. In addition, the domain expertise of Sagility helps in faster client onboarding and outsourcing of services, which is important for cross-selling and acquiring new clients.

Outcome-led business model driving efficiency gains

The value proposition of the company is the measurable cost transformation. As opposed to the manpower-based service provision, Sagility offers process re-engineering, automation, and platform-based solutions.

The report indicates that the company is increasingly entering into outcome-based commercial models where the pricing is related to the value created or the cost benefit delivered to the client, which includes PMPM-based models. This improves the revenue quality and the relationship with the clients.

AI to enhance, not replace, healthcare workflows

One of the most significant parts of the report is where it discusses why AI is not likely to replace Sagility’s business model. The US healthcare system is subject to rigorous regulatory oversight by organizations such as CMS, state regulators, the Office of Inspector General, HIPAA, and the False Claims Act.

This is because healthcare is auditable, explainable, and must be compliant. Therefore, there is still room for human judgment. Claims processing, billing, and contracts with payers and providers also have to be interpreted. Furthermore, there is also the presence of legacy systems, which makes it difficult for AI to be used.

Growth roadmap, margins, and expansion initiatives

Management is aiming to achieve low to mid-teens growth based on deeper penetration of existing accounts, cross-selling, and expansion of the current statements of work, along with an increasing emphasis on small and mid-market players.

Management also sees opportunities in their top accounts in claims, clinical operations, and payment integrity solutions. New capability expansion opportunities include Medicare acquisition, end-to-end payment integrity, HEDIS + Stars, and Synchrony-related opportunities.

With regards to profitability, management is confident that the company will be able to maintain its 24-25 percent  EBITDA margin even after passing on some of the productivity gains from AI to the customers. The provider business, which contributes 10 percent  of the revenue today, is also expected to grow over time.

Valuation outlook and earnings visibility

The brokerage expects Sagility to achieve a revenue CAGR of 20 percent , EBIT CAGR of 28 percent , and PAT CAGR of 23 percent  from FY25-FY28, driven by higher volumes from key clients, cross-selling, new client acquisition, and Broadpath synergies.

Maintains Buy rating and target of INR 58, against CMP of INR 40, implying a potential upside of 45 percent , though the thesis primarily focuses on the structural growth from outsourcing, as against the target.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Why Sagility Is Gaining Attention Amid Rising US Healthcare Outsourcing Demand? appeared first on Trade Brains.